Table 1 Description of instrumental variable (IV) for each measure.

From: Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study

Exposures

No. of SNPs for the IV

Variance explained by the IV (R2)a

Sample size of exposure GWAS

Population

Reference (PMID)

MVPA

7

0.0007

385,790

European

Klimentidis et al.15 (29899525)

AMPA

5

0.002

91,105

European

Doherty et al.16 (30531941)

AMPAb

3

0.001

91,105

European

Doherty et al.16 (30531941)

Sedentary time

6

0.001

91,105

European

Doherty et al.16 (30531941)

BMI

68

0.0232

322,154

European

Locke et al.60 (25673413)

Body fat percentage

370

0.053

331,117

European

Bycroft et al.61 (30305743)

Waist circumference

59

0.010

224,459

European

Shungin et al.62 (25673412)

AFR

15

0.002

362,499

European

Rask-Andersen et al.11 (30664634)

TFR

50

0.002

362,499

European

Rask-Andersen et al.11 (30664634)

LFR

46

0.002

362,499

European

Rask-Andersen et al.11 (30664634)

  1. GWAS genome-wide association study, MVPA self-reported moderate-to-vigorous physical activity, AMPA acceleration vector magnitude physical activity, SNP single-nucleotide polymorphism, IV instrumental variable, BMI body mass index, AFR arm fat ratio, LFR leg fat ratio, TFR trunk fat ratio.
  2. aR2 was estimated base on the formula: \(2 \times {\mathrm{EAF}}\times (1-{\mathrm{EAF}})\times \beta^{2}\).
  3. bThreshold at P < 5 × 10−9.